子宫内膜异位症风险与激素避孕药使用:一项全国性队列研究
瑞典全国登记数据的回顾性队列研究纳入2005至2017年间720805名12-27岁女性,分析激素避孕药使用与子宫内膜异位症诊断风险的关联。12-14岁即开始使用激素避孕药者诊断风险升高(aHR 2.53,95%CI 2.21-2.90),使用超过1年者风险降低(aHR 0.53,95%CI 0.48-0.59),使用超过三种类型激素避孕药与风险约翻倍相关(aHR 2.31,95%CI 1.71-3.12)。
要点
- 12-14岁开始使用激素避孕药者,子宫内膜异位症诊断风险较17岁及以上开始者升高(aHR 2.53)。
- 使用超过三种类型激素避孕药与子宫内膜异位症风险约翻倍相关(aHR 2.31)。
- 使用激素避孕药超过1年与诊断风险降低相关(aHR 0.53)。
核心结论
- 早期使用激素避孕药及未能找到合适激素避孕方法被识别为日后子宫内膜异位症诊断的警示信号。
- 较长使用激素避孕药可降低子宫内膜异位症诊断风险。
研究设计与样本
- 回顾性队列研究,基于瑞典国家登记数据。
- 队列纳入2005-2017年间720805名12-27岁女性,包括获得与未获得子宫内膜异位症诊断者(参照组)。
- 风险以粗风险比和调整风险比(HR和aHR)及95%置信区间(95%CI)表示,调整年龄、教育水平、婚姻状况、产次、出生国家及不孕、痛经或抑郁诊断。
主要发现
- 期间3268名女性被诊断为子宫内膜异位症(0.45%)。
- 12-14岁开始使用激素避孕药者较17岁及以上开始者诊断风险更高(aHR 2.53,95%CI 2.21-2.90)。
- 使用超过三种类型激素避孕药与子宫内膜异位症风险约翻倍相关(aHR 2.31,95%CI 1.71-3.12)。
- 使用激素避孕药超过1年与子宫内膜异位症风险降低相关(aHR 0.53,95%CI 0.48-0.59)。
- 子宫内膜异位症女性更常见痛经、抑郁或不孕。
关键数值与推荐
- 12-14岁开始使用激素避孕药者aHR 2.53(95%CI 2.21-2.90),参照组为17岁及以上开始者。
- 使用超过三种类型激素避孕药者aHR 2.31(95%CI 1.71-3.12)。
- 使用激素避孕药超过1年者aHR 0.53(95%CI 0.48-0.59)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate whether an early need of hormonal contraceptive (HC), or a failure to find a suitable method, are warning signs for endometriosis. DESIGN: A retrospective cohort study. SETTING: Sweden. POPULATION: The cohort consisted of 720 805 women aged 12-27 years during the period 2005-2017. All women, regardless of whether they received a diagnosis of endometriosis or not (reference group), were included. METHODS: We used data from Swedish national registers. Risks are expressed as crude and adjusted hazard ratios (HRs and aHRs, respectively) with 95% confidence intervals (95% CIs), adjusted for age, education level, civil status, parity, country of birth, and diagnoses of infertility, dysmenorrhea or depression. MAIN OUTCOME MEASURES: A diagnosis of endometriosis between 12 and 27 years of age. RESULTS: During this period, 3268 women were diagnosed with endometriosis (0.45%). Women who started HC at the ages of 12-14 years had a higher risk of receiving the diagnosis (aHR 2.53, 95% CI 2.21-2.90) than those who began at age 17 years or older. Having tried more types of HCs was associated with a twofold increased risk of endometriosis (more that three types of HC, aHR 2.31, 95% CI 1.71-3.12). Using HC for more than 1 year was associated with a decreased risk of endometriosis (>1 year, aHR 0.53, 95% CI 0.48-0.59). Women with endometriosis more commonly had dysmenorrhea, depression or infertility. CONCLUSIONS: The use of HCs at an early age and a failure to find a suitable HC were identified as warning signs of later receiving an endometriosis diagnosis. A longer duration of HC usage reduced the risk of receiving the diagnosis.
引用
- Obern C, Olovsson M, Tydén T, et al. Endometriosis risk and hormonal contraceptive usage: A nationwide cohort study. BJOG. 2024. PMID: 38511416. doi:10.1111/1471-0528.17812
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。